The latest updates on our research and how it is improving people’s lives.
Kennedy Trust gift to help drive forward research into inflammatory and musculoskeletal diseases at Oxford
30 November 2023
Two professorships in translational medicine have been endowed at the Kennedy Institute of Rheumatology thanks to a generous gift from the Kennedy Trust for Rheumatology Research.
New discovery furthers our understanding of how critical immune cells are controlled during an infection
21 November 2023
A recent publication from Audrey Gérard’s lab looks at how a specific protein, called IFNγ, can coordinate CD8+ T cell responses during a flu infection.
31 October 2023
The annual Oxford Myeloma Workshop brings together experts in myeloma research, clinical care, patient advocates and industry representatives, to help international efforts to improve patient lives affected by multiple myeloma. Multiple myeloma is the second most common among all blood cancers, is currently incurable and puts massive strains on patient quality of life with a significantly higher proportion (10 fold) share in health care costs.
27 October 2023
As demand for shoulder replacement surgery grows, a new study finds that up to 1 in 6 patients are having to travel to a different region for surgery, and exposes a year on year increase in the risk of serious adverse events after surgery that require admission to hospital.
First UK spine fracture patients identified by NHS-X and Nanox.AI Artificial Intelligence research study
20 October 2023
The NHS ADOPT study has now begun to automatically identify patients with vertebral fracture, by using Nanox.AI an Artificial Intelligence (AI) programme to review thousands of hospital computed tomography (CT) scans. The patients are now being fast-tracked for bone health assessment by an NHS osteoporosis team.
19 October 2023
The Oxford Translational Myeloma Centre (OTMC) will be a collective force of research, outreach and patient care that will transform treatment opportunities for multiple myeloma cancer patients.
18 October 2023
Congratulations to Daniele Cotton winner of St Edmund Hall’s graduate research journal prize for his article ‘Jailbreak – Preventing Metastatic Cancer.’
13 October 2023
A single-cell resolution atlas of the human musculoskeletal system could be transformative to understanding and treating conditions including arthritis, cancer and fractures.
28 September 2023
The early warning signs of psoriatic arthritis (PsA) can be hard to spot. Any delay in diagnosis of PsA can leave patients uncomfortable and in pain. But slow diagnosis is all too common, according to Professor Laura Coates. She is leading a new study called HPOS, that is looking for 2000 UK volunteers to chart their psoriasis symptoms, and which may help to explain why one third of psoriasis patients to go on to develop arthritis.
25 September 2023
Researchers at NDORMS have found a protein to block the growth of cancer stem-like cells as a possible treatment for pancreatic cancer.
15 September 2023
Three new Oxford-BMS Fellowships were announced across the Medical Sciences Division to support translational research projects.
Professor Chris Lavy named Honorary Fellow of the Royal College of Physicians and Surgeons of Glasgow
13 September 2023
NDORMS Professor of Orthopaedic and Tropical Surgery Chris Lavy has been made an Honorary Fellow of the Royal College of Physicians and Surgeons of Glasgow.
12 September 2023
Arthrofibrosis is the build-up of too much scar tissue (fibrosis) after an injury or surgery resulting in a stiffening of a joint and causing pain and disability. It’s common following knee replacement for osteoarthritis where 1 in 4 affected patients require additional surgery to correct the fibrosis and restore motion in the knee joint.
Fair safe medical AI: a South Asia case study to co-develop local agency & trust leaving no one behind
11 September 2023
The Planetary Health Informatics Lab led by Associate Professor Sara Khalid at NDORMS has announced that it is a winner of a Global Grand Challenges award – an initiative fostering innovation to solve pressing global health and development problems and funded by the Bill & Melinda Gates Foundation.
4 September 2023
A new study looked at the effect of patient genetics on their response to secukinumab, an anti-IL17 therapy commonly used to treat inflammatory conditions including arthritis and psoriasis. No link was found between a patient’s genetic variants and their response to therapy. This study challenges the idea that genetics might significantly account for the variable responses to anti-IL17 therapy seen in the clinic.
3 August 2023
Research into the onset and progression of diseases affecting musculoskeletal soft tissues could be greatly advanced using novel 3D models say NDORMS researchers in a review published in The Lancet Rheumatology.